Market Overview:
The global glucose sterile injection water market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of diabetes, rising demand for better and more convenient modes of drug delivery, and growing number of approvals for novel drugs. Based on type, the global glucose sterile injection water market can be segmented into infusion bottle, infusion bag, and other types. The infusion bottle segment is expected to account for the largest share in terms of revenue in 2018 owing to its high usage rates across hospitals and clinics. By application, the hospital segment is expected to account for the largest share in terms of revenue in 2018 followed by clinic applications.
Product Definition:
A sterile, aqueous solution of glucose used as an intravenous fluid. Glucose is the body's primary source of energy and is essential for the proper functioning of the brain and other organs.
Infusion Bottle:
Infusion bottles are used to administer drugs and fluids into the body. They are majorly used for intravenous (IV) fluid administration, however, they can be used for oral fluid administration as well. The growth factor in the market is increasing demand from emerging economies such as India and China where prevalence of diabetes is on a rise due to sedentary lifestyle coupled with genetic predisposition.
Diabetes has become one of the most common diseases in both developed.
Infusion Bag:
An infusion bag is a closed container which contains fluid. It is used to transfer liquid into or from the body of a patient by means of intravenous infusion. The term “infusion” refers to the process, not just the delivery method. An infusion can be done with sterile water or another sterile solution containing drugs and nutrients as well as fluids like saline (0 electrolyte), dextrose in corn syrup (dextrose 50%), and lactated Ringers solutions etc.
Application Insights:
The hospital application segment accounted for the largest share of 92.5% in 2017. The growing number of diabetic patients and rising prevalence of chronic diseases are the key factors driving the demand for GS WI in hospitals, clinics and other healthcare facilities. Moreover, increasing government initiatives to control diabetes through diet & exercise along with awareness campaigns is expected to boost product demand over the forecast period.
Clinical trials have proved that glucosinolate-free GS WI can reduce blood pressure as well as cholesterol levels when compared with conventional products containing glucosinolates such as garlic extract or onion extract. This has led to an increased demand for these sterile injectable water products in clinical trials over recent years, which is expected to drive market growth during the forecast period from 2018 to 2030 (see Table 1).
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of manufacturers and suppliers. The region is expected to maintain its dominance over the forecast period as well. This can be attributed to increasing cases of diabetes, rising healthcare expenditure, and high adoption rate for advanced products & technologies in this region.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to factors such as improving economic conditions, growing population along with rising healthcare expenditure & awareness regarding advanced glucose control solutions in emerging countries like China & India. Moreover, an increase in government initiatives for controlling diabetes is also expected favorably impact regional market growth over the next eight years (2030).
Growth Factors:
- Increasing demand for glucose sterile injection water in the pharmaceutical and biotechnology industries for various applications such as research, development, and production
- Growing prevalence of diabetes and other chronic diseases that require regular blood glucose monitoring
- Technological advancements in glucose sterile injection water manufacturing process that improve quality and purity of the product
- Rising awareness about the benefits of using sterile injection water for dissolving drugs and preparing injections
- Expansion of distribution channels by manufacturers to reach a wider customer base
Scope Of The Report
Report Attributes
Report Details
Report Title
Glucose Sterile Injection Water Market Research Report
By Type
Infusion Bottle, Infusion Bag, Other
By Application
Hospital, Clinic, Other
By Companies
Pfizer, B. Braun, Baxter, Hikma Pharmaceuticals, Fresenius, Otsuka Pharmaceutical, Kelun, SSY Group Limited, Zhejiang Tianrui Pharmaceutical, Shapuaisi Pharma, Zhuhai Tongyuan Pharmaceutical Co., Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
190
Number of Tables & Figures
133
Customization Available
Yes, the report can be customized as per your need.
Global Glucose Sterile Injection Water Market Report Segments:
The global Glucose Sterile Injection Water market is segmented on the basis of:
Types
Infusion Bottle, Infusion Bag, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- B. Braun
- Baxter
- Hikma Pharmaceuticals
- Fresenius
- Otsuka Pharmaceutical
- Kelun
- SSY Group Limited
- Zhejiang Tianrui Pharmaceutical
- Shapuaisi Pharma
- Zhuhai Tongyuan Pharmaceutical Co., Ltd.
Highlights of The Glucose Sterile Injection Water Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Infusion Bottle
- Infusion Bag
- Other
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Glucose Sterile Injection Water Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Glucose sterile injection water is a clear, colorless liquid that is used to inject glucose into the bloodstream. It is made from purified water and glucose.
Some of the major players in the glucose sterile injection water market are Pfizer, B. Braun, Baxter, Hikma Pharmaceuticals, Fresenius, Otsuka Pharmaceutical, Kelun, SSY Group Limited, Zhejiang Tianrui Pharmaceutical, Shapuaisi Pharma, Zhuhai Tongyuan Pharmaceutical Co., Ltd..
The glucose sterile injection water market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Glucose Sterile Injection Water Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Glucose Sterile Injection Water Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Glucose Sterile Injection Water Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Glucose Sterile Injection Water Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Glucose Sterile Injection Water Market Size & Forecast, 2018-2028
4.5.1 Glucose Sterile Injection Water Market Size and Y-o-Y Growth
4.5.2 Glucose Sterile Injection Water Market Absolute $ Opportunity
Chapter 5 Global Glucose Sterile Injection Water Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Glucose Sterile Injection Water Market Size Forecast by Type
5.2.1 Infusion Bottle
5.2.2 Infusion Bag
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Glucose Sterile Injection Water Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Glucose Sterile Injection Water Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Glucose Sterile Injection Water Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Glucose Sterile Injection Water Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Glucose Sterile Injection Water Analysis and Forecast
9.1 Introduction
9.2 North America Glucose Sterile Injection Water Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Glucose Sterile Injection Water Market Size Forecast by Type
9.6.1 Infusion Bottle
9.6.2 Infusion Bag
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Glucose Sterile Injection Water Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Glucose Sterile Injection Water Analysis and Forecast
10.1 Introduction
10.2 Europe Glucose Sterile Injection Water Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Glucose Sterile Injection Water Market Size Forecast by Type
10.6.1 Infusion Bottle
10.6.2 Infusion Bag
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Glucose Sterile Injection Water Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Glucose Sterile Injection Water Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Glucose Sterile Injection Water Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Glucose Sterile Injection Water Market Size Forecast by Type
11.6.1 Infusion Bottle
11.6.2 Infusion Bag
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Glucose Sterile Injection Water Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Glucose Sterile Injection Water Analysis and Forecast
12.1 Introduction
12.2 Latin America Glucose Sterile Injection Water Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Glucose Sterile Injection Water Market Size Forecast by Type
12.6.1 Infusion Bottle
12.6.2 Infusion Bag
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Glucose Sterile Injection Water Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Glucose Sterile Injection Water Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Glucose Sterile Injection Water Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Glucose Sterile Injection Water Market Size Forecast by Type
13.6.1 Infusion Bottle
13.6.2 Infusion Bag
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Glucose Sterile Injection Water Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Glucose Sterile Injection Water Market: Competitive Dashboard
14.2 Global Glucose Sterile Injection Water Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 B. Braun
14.3.3 Baxter
14.3.4 Hikma Pharmaceuticals
14.3.5 Fresenius
14.3.6 Otsuka Pharmaceutical
14.3.7 Kelun
14.3.8 SSY Group Limited
14.3.9 Zhejiang Tianrui Pharmaceutical
14.3.10 Shapuaisi Pharma
14.3.11 Zhuhai Tongyuan Pharmaceutical Co., Ltd.
